<DOC>
	<DOCNO>NCT00298350</DOCNO>
	<brief_summary>The purpose study evaluate non-inferiority ritonavir-boosted GS-9137 relative ritonavir-boosted Comparator Protease Inhibitor use part combination antiretroviral regimens subject fail , fail , protease inhibitor therapy .</brief_summary>
	<brief_title>Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor ( ) Combination With Background ART .</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>Integrase Inhibitors</mesh_term>
	<criteria>HIV RNA great equal 1000 c/mL . Failed/Failing protease inhibitor base antiretroviral therapy . Stable antiretroviral therapy great equal 30 day prior screen . Negative Serum Pregnancy Test . GFR Cockcroft Gault great equal 80 mL/min . AST &amp; ALT less equal 2.5x ULN . Total Bilirubin less equal 1.5 mg/dL . Albumin great 3.5 mg/dL . Prothrombin Time INR 1.01.4 Platelets great equal 50,000 . Hemoglobin great equal 8.0 mg/dL . Absolute Neutrophil Count great equal 1000 . New AIDS define condition within 30 day baseline . Prior treatment HIV1 integrase inhibitor ( except patient 183101 ) . Ascites encephalopathy . Breast Feeding . Cancer Diagnosis ( besides Kaposi Sarcoma Basal Cell Carcinoma ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Phase 2</keyword>
	<keyword>Phase II</keyword>
	<keyword>Randomized</keyword>
	<keyword>Controlled</keyword>
	<keyword>Comparator</keyword>
	<keyword>Partially Blind</keyword>
	<keyword>Protease Inhibitors</keyword>
	<keyword>Integrase Inhibitors</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Antiretroviral Agents</keyword>
	<keyword>ART</keyword>
	<keyword>ARV</keyword>
	<keyword>Highly Activity Antiretroviral Therapy</keyword>
	<keyword>HAART</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>